H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act (119th Congress)
Summary
H.R.1518, the "New Era of Preventing End-Stage Kidney Disease Act," aims to improve the prevention, diagnosis, and treatment of rare kidney diseases. The bill focuses on research, public awareness, and provider education related to these diseases. It amends the Public Health Service Act and the Social Security Act to establish centers of excellence, conduct studies, and enhance training programs.
Expected Effects
The bill will likely lead to increased funding for research into rare kidney diseases and improved training for healthcare providers. It also mandates studies to better understand and address the factors contributing to these diseases. Ultimately, this could result in earlier diagnosis, better treatment options, and improved outcomes for patients with rare kidney diseases.
Potential Benefits
- Increased research funding for rare kidney diseases.
- Improved training and education for healthcare providers.
- Enhanced public awareness of rare kidney diseases, especially in underserved communities.
- Potential for earlier diagnosis and more effective treatments.
- Focus on addressing disparities in care for disproportionately affected populations.
Potential Disadvantages
- The bill's reliance on appropriations means funding is not guaranteed.
- The study mandated by the bill could delay actual implementation of solutions.
- The focus on rare kidney diseases might divert resources from more common kidney conditions.
- The bill does not address the underlying causes of health disparities, such as poverty and lack of access to healthcare.
- Potential for increased healthcare costs associated with genetic testing and specialized treatments.
Constitutional Alignment
The bill appears to align with the Constitution's general welfare clause (Preamble). It promotes scientific research and healthcare access, which can be argued as promoting the general welfare. The bill's provisions regarding healthcare and research fall under the purview of Congress's power to regulate interstate commerce (Article I, Section 8), as healthcare services and research often involve interstate transactions and the movement of goods and services across state lines.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).